Watch: NHC CEO Boutin Testified Before House Energy and Commerce Subcommittee on Drug Pricing

Thursday, March 21, 2019

National Health Council Chief Executive Officer Marc Boutin, JD, testified at a House Committee on Energy & Commerce Health Subcommittee hearing on "Lowering the Cost of Prescription Drugs: Reducing Barriers to Market Competition." 

The hearing focused on seven bills designed to make it easier for generic drugs to reach the market, including the CREATES Act, FAST Generics Act, pay-for-delay ban, BLOCKING Act, the FAIR Generics Act, the Orange Book Transparency Act, and Purple Book Continuity Act.

To read Boutin’s full written testimony, click here.

Watch the recording of the hearing below.